The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro

Stephen Blake, Timothy Hughes, Graham Mayrhofer, Alan Lyons

    Research output: Contribution to journalArticle

    80 Citations (Scopus)
    Original languageEnglish
    Article numberCC
    Pages (from-to)330-339
    Number of pages10
    JournalClinical Immunology
    Volume127
    Issue number3
    Publication statusPublished - 2008

    Cite this